Microglia modulate neurodegeneration in Alzheimer’s and Parkinson’s diseases

Cited by (413)

Items 401–413 of 413

1. OTUB1 non-canonically inhibits TAB2 ubiquitination to govern microglia-mediated neuroinflammation
   Zijun Cao, Zhenhu Zhu, Ping Zeng, Fuqi Mei, Deqi Wang, Jun Xu, Yanqi Xu, Kangmin Chen, Chushan Wei, Jiangyun Shen et al. · 2026 · EMBO Molecular Medicine
2. Brain-muscle axis regulation of neuroinflammation and sarcopenia in Parkinson’s disease: the bridging role of lactylation
   Maoyuan Wang, Huiwen Huang, Xiyan Lan, An Yin, Qiong Deng, Yanbiao Zhong, MaoYuan Wang · 2026 · Neurological Sciences
3. Microglial PTP1B promotes synaptic pathology and cognitive deficits in chronic Toxoplasma gondii infection
   Daxiang Xu, Cheng He, Huiling Lv, Jensen G Weedor, Yihui Xing, Zhicheng He, Pengxue Jing, Wenjing Cui, Xiaoying Yang, Guihua Zhao et al. · 2026 · Brain Behavior and Immunity
4. RVG-functionalized microglial membrane–coated cerium–gallic acid metal–organic frameworks for multi-target Alzheimer's therapy
   Fengmei Yang, Yuehua Chen, Yujiao Yan, Ruixin Zhao, Liran Deng, Die Tian, Qi Wang, Meng Xie · 2026 · Journal of Colloid and Interface Science
5. Lipid Metabolism in Central Nervous System Diseases: Pathological Mechanisms and Therapeutic Advances
   Jiayan Yuan, Shixue Huang, Kun Jiao, Shu Yang, Xuhui Ge, Wei Liu, Wei Wang, Haoming Shu, Xuhui Zhou · 2026 · CNS Neuroscience & Therapeutics
6. Infection with Western equine encephalitis virus causes severe regional glial reactivity and neurodegeneration in the hippocampus with progressive accumulation of amyloid-β
   Aidan M. Briggs, Adam J. Schuller, Megan R. Hager, Omar A. Yanouri, Savannah M. Rocha, Collin M. Bantle, Debotri Chatterjee, Richard Jay Smeyne, Ronald B. Tjalkens · 2026 · Journal of Neuropathology & Experimental Neurology
7. From HIV to SARS-CoV-2 associated neurological disorder (“HAND” to “SAND”): Viral infection as a “time-bomb“ for the aging brain
   Mark John Millan · 2026 · Neuroscience Applied
8. Exploring the toxicological impact of BDE-209 on neurodegenerative diseases through network toxicology, molecular docking, molecular dynamics simulation and in-vitro study
   Xu Li, Shenghan Zhang, Yinuo Liu, Xi Yu, Litong Han, Yingjuan Liu · 2026 · Toxicology and Applied Pharmacology
9. Autophagy-lysosomal pathway in neurodegeneration
   Samantha R. McDonough, Aditya K. Rao, Jacqueline M. McAleer, Bergan M. Babrowicz, Manu Sharma · 2026 · Molecular Neurodegeneration Advances
10. Targeting glial PD-1/PD-L1 restores microglial homeostasis and reduces neuronal hyperactivity in an Alzheimer’s disease model
    Taeyoung Park, Leechung Chang, Seung Won Chung, Seowoo Lee, Sungjun Bae, Carlo Condello, Yong Ho Kim, Jaecheol Lee, Han-Joo Kim, Ho-Keun Kwon et al. · 2026 · Science Advances
11. Remodeling of the brain immune microenvironment in Alzheimer’s disease: interactions among microglia, astrocytes, complement, and the neurovascular unit
    Tong Wang, Lu Wang, Jianing Cao, Yi Zhao, Zongling He, Fengmei Lu · 2026 · Frontiers in Immunology
12. BindingDB Entry 50022694: Polypharmacological Drug Design Guided by Integrating Phenotypic and Restricted Fragment Docking Strategies.
    BindingDB · 2026 · UC San Diego
13. Synaptic transmission and plasticity: molecular mechanisms, biological functions and therapeutic opportunities in neurodegenerative diseases
    Jianxu Sun, Ge Gao, Sitong Wang, Shuai Li, Jinglan Tang, Hongmei Liu, Tie-Shan Tang · 2026 · Signal Transduction and Targeted Therapy